Additionally, MSC2-sourced TGF-β and IL-10 downregulate production of inflammatory cytokines and reduce cytotoxicity of Th1 and Th17 cells and CTLs, contributing to the enhanced tumor growth and progression [35, 36]. Here, IL10 is linked to neoplasm.